Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 521 - Heterocyclic compounds containing unspecified hetero rings
Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
05/2003
05/13/2003US6563003 Process to produce amino alcohol salts
05/13/2003US6562964 Inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases or other disorders
05/13/2003US6562861 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
05/13/2003US6562854 Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disorders
05/13/2003US6562811 Pyridine derivatives
05/13/2003CA2261724C Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase
05/13/2003CA2021467C Heterocyclically substituted sulfonylureas, process for their preparation, and their use as herbicides or plant growth regulators
05/08/2003WO2003037875A1 Developer constituents and their use for dying keratin fibers
05/08/2003WO2003037871A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003US20030087935 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
05/08/2003US20030087923 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
05/08/2003CA2465344A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/07/2003EP1307431A2 Efficient ligand-mediated ullmann coupling of anilines and azoles
05/07/2003EP0912510B1 Nickel catalyzed addition of -nh- containing compounds to vinyl and aryl halides
05/07/2003EP0765314B1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
05/07/2003EP0749417B1 Cyano compounds and preparations thereof
05/07/2003CN1416423A 2,4,Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
05/07/2003CN1107671C Imide derivatives
05/06/2003US6559303 Bridgehead atoms are bonded to one or more bridges that interconnect one or more ring systems thereby forming a large cyclic structure. Located in each bridge are two or more nitrogenous moieties that are derivatized with chemical
05/06/2003US6559166 A class of phenylsulphonyl derivatives wherein the sulphonyl moiety is also attached to an N-arylalkyl-substituted azetidine, pyrrolidine or piperidine ring are selective antagonists of the human 5-HT2A receptor and are therefore
05/06/2003US6559163 Agonists, antagonists or inverse agonists for GABAA brain receptors; useful in diagnosis and treatment of anxiety, depression
05/06/2003US6558435 Reactive crystallization method to improve particle size
05/02/2003EP1305319A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
05/02/2003EP1305294A2 Imidazolyl derivatives
05/02/2003EP1305274A2 Novel c-4 substituted retinoids
05/02/2003EP1001813B1 Pharmaceutical formulations containing voriconazole
05/02/2003EP0772593B1 Thiopyridyl compounds for controlling helicobacter bacteria
05/01/2003WO2003035644A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
05/01/2003WO2003035602A1 Lipid modulators
05/01/2003WO2003035066A1 2-aminoquinolone derivatives for use as impdh inhibitors
05/01/2003WO2003035065A1 Benzimidazoles and analogues and their use as protein kinases inhibitors
05/01/2003US20030083504 N- (4-carbamimidoyl-phenyl) -glycine derivatives
05/01/2003US20030083489 Method of synthesizing polynucleotides using ionic liquids
05/01/2003US20030083332 N-heterocyclic derivatives as NOS inhibitors
05/01/2003US20030083327 Inhibitors of Aurora-2 protein kinases and Glycogen synthase kinase-3 (GSK-3); cancer, diabetes, Alzheimer's disease, and schizophrenia treatment
05/01/2003US20030080312 Reacting organic base and an alkylating agent, wherein the alkylating agent is a fluorinated ester or an alkyl sulfonate
05/01/2003CA2466813A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
04/2003
04/29/2003US6555555 Fused thiophone derivatives and drugs containing the same as the active ingredient
04/29/2003US6555541 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
04/29/2003US6555539 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
04/24/2003WO2003033483A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
04/24/2003WO2003033482A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors
04/24/2003WO2003033478A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors
04/24/2003WO2003033477A1 Alkynlated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitor
04/24/2003WO2003032999A1 Alkyne matrix metalloproteinase inhibitors
04/24/2003WO2003032997A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same
04/24/2003WO2003032986A1 2' -methyl-5-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2003WO2003032980A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2003WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors
04/24/2003US20030078418 Useful potentiators of beta -lactam antibiotics; therapy
04/24/2003US20030078275 For therapy of cancer, diabetes and Alzheimer's disease
04/24/2003US20030078270 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
04/24/2003US20030078265 Inhibitors of nitric oxide synthase (nos)
04/24/2003US20030078166 Pyrazole compounds useful as protein kinase inhibitors
04/24/2003CA2463159A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors
04/24/2003CA2462442A1 Alkyne matrix metalloproteinase inhibitors
04/23/2003EP1303514A1 Process for preparing azacycloalkanoylaminothiazoles
04/23/2003EP1303512A1 Process for preparing arylacetylaminothiazoles
04/23/2003EP1077975B1 Water soluble azoles as broad-spectrum antifungals
04/23/2003EP0993442B1 Hydrazine derivatives
04/23/2003EP0889881B1 New triazoles as therapeutic agents for fungal infections
04/23/2003CN1413216A Azolyalkyl-oxa (di) azolyl pyri (mi) dine derivatives, method for their production and use as pesticides
04/22/2003US6552203 Optionally oxygenated hydrogenated thiophenes, thiopyrans and thiomorpholines containing hydroxyethylamine groups
04/17/2003WO2003031448A1 Reverse-turn mimetics and method relating thereto
04/17/2003WO2003031437A1 Propylcarbamate derivatives as inhibitors of serine and cysteine proteases
04/17/2003WO2003031410A1 Ligands of melanocortin receptors and compositions and methods related thereto
04/17/2003WO2003030909A1 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
04/17/2003WO2003030902A1 Imidazole derivates as anti-inflammatory agents
04/17/2003WO2002098852A3 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
04/17/2003WO2001094341A9 Quinazoline derivatives for the treatment of tumours
04/17/2003US20030073852 Anticancer agents
04/17/2003US20030073849 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
04/17/2003US20030073847 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
04/17/2003US20030073718 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease
04/17/2003US20030073706 Fused thiophone derivatives and drugs containing the same as the active ingredient
04/17/2003US20030073687 Alzheimer's disease; anticancer agents; antidiabetic agents
04/17/2003US20030073669 N-heterocyclic derivatives as NOS inhibitors
04/16/2003EP1302468A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds
04/16/2003EP1302463A1 Medicine comprising dicyanopyridine derivative
04/16/2003EP0998451B1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use
04/16/2003CN1105706C Cyclic amidino agents useful as nitric oxide synthase inhibitors
04/15/2003US6548526 Isothiazole derivatives useful as anticancer agents
04/15/2003US6548499 Substituted quinoxaline derivatives as interleukin-8 receptor antagonists
04/10/2003WO2003029244A1 Process for preparing pyridyl-alkylsulfonyl pyrazole derivatives
04/10/2003WO2003004493A8 Novel compounds, their preparation and use
04/10/2003US20030069430 Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects
04/10/2003US20030069424 Indolylmaleimide derivatives
04/10/2003US20030069284 Anticancer agent
04/10/2003US20030069275 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
04/10/2003US20030069241 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents
04/10/2003US20030069210 Especially imidazolyl- or 1,2,4-triazolyl- pyrimidine derivatives
04/10/2003CA2457798A1 Process for preparing heterocyclo-alkylsulfonyl pyrazole derivatives
04/09/2003EP1300401A1 Five-membered-ring compound
04/09/2003EP1299383A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
04/09/2003EP1299374A1 Novel non-psychotropic cannabinoids
04/09/2003EP0901472B1 Mercapto-imidazolyl derivatives and their use as microbicides
04/09/2003EP0873123B1 Inhibitors of protein isoprenyl transferases
04/09/2003CN1409626A Catechol oximes and their use in cosmetic and dermatological preparations
04/09/2003CN1105102C Amino-butenate compound and preparation method thereof
04/08/2003US6545163 Process to prepare 1-aryl-2-(1-imidazolyl) alkyl ethers and thioethers
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 163